Author:
Jalde Shivakumar S.,Choi Hyun Kyung
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Microbiology
Reference113 articles.
1. Aboklaish, A.F., Okujava, R., El-Bouseary, M., Zampaloni, C., Najera, I., Bradley, K., Walsh, T.R., and Tyrrell, J.M. 2018. Nacubactam antibacterial activity alone and in combination with β-lactam antibiotics against contemporary Enterobacteriaceae clinical isolates. European Congress of Clinical Microbiology and Infectious Diseases (28th ECCMID) Madrid Spain, Abs. P1034.
2. Aktaş, Z., Kayacan, C., and Oncul, O. 2012. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae. Int. J. Antimicrob. Agents39, 86–89.
3. Alvarez, M., Tran, J.H., Chow, N., and Jacoby, G.A. 2004. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob. Agents Chemother.48, 533–537.
4. Ambler, R.P. 1980. The structure of β-lactamases. Philos. Trans. R. Soc. Lond. B Biol. Sci.289, 321–331.
5. Bebrone, C. 2007. Metallo-β-lactamases (Classification, activity, genetic organization, structure, Zinc coordination) and their superfamily. Biochem. Pharmacol.74, 1686–1701.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献